Login / Signup
Weng Shiwen
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 1
Top Topics
Replacement Therapy
Temporal Lobe Epilepsy
Data Analysis
Phase Iii
Top Venues
CNS neuroscience & therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Shan Wei
,
Weng Shiwen
,
Chang Cao-Wenjing
,
Yang Huajun
,
Wang Qun
A randomized, double-blind, placebo-controlled, dose-escalating phase IIa trial to evaluate the safety, tolerability, efficacy, and pharmacokinetics of multiple oral doses of Pynegabine tablets as add-on therapy in patients with focal epilepsy.
CNS neuroscience & therapeutics
30 (9) (2024)